Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122568092 | 12256809 | 2 | F | 20160408 | 20160412 | 20160831 | PER | US-GLAXOSMITHKLINE-US2016GSK047470 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122568092 | 12256809 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | U | 18644 | |||||||||||
| 122568092 | 12256809 | 2 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 122568092 | 12256809 | 3 | SS | CEFTIN | CEFUROXIME AXETIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122568092 | 12256809 | 1 | Product used for unknown indication |
| 122568092 | 12256809 | 2 | Product used for unknown indication |
| 122568092 | 12256809 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122568092 | 12256809 | Dermatitis | |
| 122568092 | 12256809 | Drug hypersensitivity | |
| 122568092 | 12256809 | Headache | |
| 122568092 | 12256809 | Rash | |
| 122568092 | 12256809 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |